PRODUCT LITERATURE

Nebivolol: A Review of its Use in the Management of Hypertension and Chronic Heart Failure

---

Nebivolol is a third-generation β-adrenoceptor antagonist. It differs from other β-adrenoceptor antagonists as it combines highly selective β1-adrenoceptor antagonist properties with nitric oxide-mediated vasodilatory actions and beneficial effects on endothelial function. Nebivolol is approved in Europe and several other countries for the treatment of essential hypertension and in Europe for the treatment of stable mild or moderate chronic heart failure (CHF) in addition to standard therapies in elderly patients aged ≥70 years.

---

Availability

Detail Information

Series Title

-

Call Number

-

Publisher

: .,

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

Nevodio

Specific Detail Info

Drugs 2006; 66 (10): 1389-1409

Statement of Responsibility

-

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment